Characterizing Biologics Using Dynamic Imaging Particle Analysis - Overcoming limitations of volumetric techniques and detecting transparent particles. - BioPharm International


Characterizing Biologics Using Dynamic Imaging Particle Analysis
Overcoming limitations of volumetric techniques and detecting transparent particles.

BioPharm International Supplements
Volume 24, Issue 8, pp. s4-s9

Figure 2: Results of a FlowCAM run with protein-based biologic sample, including (left) graphs and summary statistics and (right) representative particle images including, protein aggregates and silicone droplets.
To demonstrate how dynamic imaging particle analysis can characterize subvisible particulates in biologics, the author analyzed a sample protein-based therapeutic using the FlowCAM (Fluid Imaging Technologies) particle imaging system. Figure 2 shows the result of the analysis, including summary statistics and representative particle images. This particular sample contained a large amount of silicone droplets. To enable the system to differentiate between various types of particles automatically, one can build a digital filter to distinguish the silicone droplets from other particulates. The filter is created by selecting a few examples of silicone droplets and instructing the software to find similar particles. The system uses a sophisticated method known as statistical pattern recognition to classify every particle automatically as being one of the class (i.e., silicone droplets) or not (3).

Table I: Number of particles found in each size category before and after silicone droplets were removed.
In this example, out of the 2844 original particles in the run, 1788 were identified as silicone droplets. Because USP <788> addresses particles larger than 10 m and larger than 25 m, the particles were sorted into two categories (see Table I). One can see a dramatic difference between the particle counts for the two categories once the silicone droplets have been removed. If the silicone droplets are considered to be a harmless byproduct of the delivery method, then excluding them from the analysis will yield different results than would be found using light obscuration according to <788>.

Figure 3: Conceptual diagram of object and image space in an optical system.
The first factor to consider when using dynamic imaging particle analysis is resolution. Unlike the human eye, which sees the world as continuous, digital images are sampled versions of the real world. This means that any given image is divided into discrete picture elements or pixels that form the whole. Thus, the imaging sensor has a discrete number of samples of the object being captured. The easiest way to visualize this is to project the sensor geometry onto the object being captured, as shown in Figure 3. In this diagram, the overall system magnification is 200%, so that the object's image is two times larger than the actual object. A more meaningful way to express this is in terms of a calibration factor equal to the size of one pixel of the sensor projected onto the object. In this case the calibration factor would be 2.5 m/pixel. Therefore, one pixel of the image covers 2.5 m in length or width. Since a pixel is the smallest unit of a digital image, this means that, in theory, the system can measure down to 2.5 m.

blog comments powered by Disqus



FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Author Guidelines
Source: BioPharm International Supplements,
Click here